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EGR-1 binding sites <p>A Genome-wide analysis of EGR-1 binding sites reveals co-localization with CpG islands and histone H3 lysine 9 binding. SP-1 binding  occupancies near EGR-1 binding sites are dramatically altered.</p>
Abstract
Background: Immediate early genes are considered to play important roles in dynamic gene
regulatory networks following exposure to appropriate stimuli. One of the immediate early genes,
early growth response gene 1 (EGR-1), has been implicated in differentiation of human monoblastoma
cells along the monocytic commitment following treatment with phorbol ester. EGR-1 has been
thought to work as a modifier of monopoiesis, but the precise function of EGR-1 in monocytic
differentiation has not been fully elucidated.
Results: We performed the first genome-wide analysis of EGR-1 binding sites by chromatin
immunoprecipitation with promoter array (ChIP-chip) and identified EGR-1 target sites in
differentiating THP-1 cells. By combining the results with previously reported FANTOM4 data, we
found that EGR-1 binding sites highly co-localized with CpG islands, acetylated histone H3 lysine 9
binding sites, and CAGE tag clusters. Gene Ontology (GO) analysis revealed enriched terms,
including binding of molecules, in EGR-1 target genes. In addition, comparison with gene expression
profiling data showed that EGR-1 binding influenced gene expression. Moreover, observation of in
vivo occupancy changes of DNA binding proteins following PMA stimulation indicated that SP1
binding occupancies were dramatically changed near EGR-1 binding sites.
Conclusions:  We conclude that EGR-1 mainly recognizes GC-rich consensus sequences in
promoters of active genes. GO analysis and gene expression profiling data confirm that EGR-1 is
involved in initiation of information transmission in cell events. The observations of in vivo
occupancy changes of EGR-1 and SP1 suggest that several types of interplay between EGR-1 and
other proteins result in multiple responses to EGR-1 downstream genes.
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Background
Regulatory gene networks, involving specific DNA elements
and various transcription regulators, control living cells. To
maintain a stable cellular state, multiple cell type-specific
transcription regulators interact with DNA binding sites in
target genes. For example, enforced expression of four tran-
scription factors (MYC, OCT3/4, KLF4 and SOX2) in differ-
entiated cells drives pluripotent-specific gene expression and
is capable of maintaining pluripotency and self-renewing
characteristics [1]. On the other hand, the molecular mecha-
nism for cell state changes following exposure to appropriate
stimuli has not been fully elucidated, although the induction
of a set of immediate early genes is thought to constitute the
first step in the cellular molecular response to stimulant sig-
nals for state changes.
Early growth response gene 1 (EGR-1; also known as NGFI-A,
K R O X - 2 4 ,  Z I F 2 6 8  o r  T I S 8 )  c o n t a i n s  a  h i g h l y  c o n s e r v e d
DNA-binding domain composed of three C2H2 classical zinc
finger motifs that belongs to the immediate early gene family.
EGR-1 is rapidly and transiently induced by various stimu-
lants, such as growth factors [2], neurotransmitters [3], hor-
mones [4], stress [5] and injury [6], and recognizes a 9 base
pair segment in GC rich regions in the promoters of target
genes. EGR-1 is also involved in cell growth [7], synaptic acti-
vation [8], apoptosis in vascular cells [9] and mitogenesis
[10]. Moreover, EGR-1 may play an essential role in cell dif-
ferentiation along the monocyte lineage. Liebermann and col-
leagues [11] reported that antisense oligomers for Egr-1
blocked macrophage differentiation in myeloid leukemia cell
lines and normal myeloblasts, and ectopic expression of Egr-
1 in cell lines and primary bone marrow resulted in activation
of the macrophage differentiation program [12,13]. However,
the precise function of EGR-1 in monocyte differentiation has
not been clearly defined.
Recently, we analyzed the transcriptional network in differ-
entiation of human myelomonocytic leukemia THP-1 cells as
a system model following treatment of phorbol 12-myristate
13-acetate (PMA) using data from the FANTOM4 consortium
[14]. Our analysis using FANTOM4 data, including microar-
rays of mRNA, deepCAGE and chromatin immunoprecipita-
tion with genome tiling array (ChIP-chip) [15], revealed that
cellular states were constrained by complex networks involv-
ing substantial numbers of both positive and negative regula-
tors. In this study, in order to investigate EGR-1 function
during monocyte differentiation, genome-wide EGR-1 bind-
ing site data were produced using ChIP-chip and integrated
with the available FANTOM4 data. Consequently, we present
a whole-genome EGR-1 binding profile and propose possible
functions of EGR-1.
Results
EGR-1 expression during THP-1 differentiation
To assess whether the expression of EGR-1 in THP-1 cells
changes during the time course of monocyte differentiation
following PMA stimulation, we analyzed microarray data in
the FANTOM4 data sets (see Materials and methods). EGR-1
mRNA was up-regulated immediately after PMA treatment,
reaching a maximum at 1 hour and decreasing dramatically
thereafter (Figure 1a). Also, quantitative RT-PCR analysis
indicated that EGR-1 mRNA in THP-1 cells was transiently
induced by PMA stimulation (data not shown). These obser-
vations of mRNA changes were similar to those reported pre-
viously using HL60 and primary human monocytes [16].
Moreover, western blotting using an EGR-1 polyclonal anti-
body assessed levels of EGR-1 protein in nuclear extracts
from untreated and PMA-stimulated cells (Figure 1b). As
expected, small amounts of EGR-1 protein were detectable in
the untreated state, while EGR-1 translation at 1 hour after
stimulation was drastically elevated and returned to pre-
stimulation levels by 48 hours. The EGR family members,
including EGR-1, EGR-2, EGR-3, EGR-4 and WT-1, share a
highly homologous DNA binding domain and three or four
zinc finger motifs. However, since the flanking regions of the
EGR family are much less conserved and the molecular sizes
of all EGR proteins but EGR-1 are less than 55 kDa, the poly-
EGR-1 expression during THP-1 differentiation Figure 1
EGR-1 expression during THP-1 differentiation. (a) Quantile normalized 
EGR-1 transcript levels were produced by Illumina Human Sentrix-6 bead 
chips v.2. (b) EGR-1 protein levels by western blotting using an EGR-1 
polyclonal antibody.
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clonal antibody against EGR-1 was judged to cross-react with
negligible amounts of other EGR family proteins. These
results show that EGR-1 mRNA and protein were significantly
and transiently expressed soon after PMA stimulation.
To test the essential role of EGR-1 in THP-1 differentiation
reported previously [11], RNA interference was employed to
specifically knockdown the EGR-1 mRNA. The small interfer-
ing RNA (siRNA) for EGR-1 was designed against a target
sequence located at the 3' end of the EGR-1 coding region and
conjugated with Alexa Fluor 555. Quantitative RT-PCR was
then used to verify siRNA-mediated down-regulation of EGR-
1 mRNA (Additional data file 1a). THP-1 cells were treated
with either EGR-1 siRNA or a negative control siRNA and
exhibited a similar efficiency of transfection (Additional data
file 1b, upper). Fourty-eight hours after transfection prior to
PMA stimulation, there was no detectable difference in mor-
phology between EGR-1 siRNA-treated cells and the negative
control. Moreover, a couple of hours after PMA treatment,
both the treated and control cells adhered to the culture dish.
However, inhibition of THP-1 differentiation by EGR-1
knockdown was observed at 48 hours after PMA stimulation
(Figure 2 and Additional data file 1b, lower). Taken together,
these data indicate that EGR-1 has an important role during
monocyte differentiation in THP-1 cells as well as other mye-
loid leukemia cell lines and normal myeloblasts.
Identification of EGR-1 binding sites in CpG islands
Although EGR-1 is thought to be a DNA binding protein with
three zinc finger motifs, and reported target genes have been
studied using single gene approaches such as reporter and gel
shift assays, EGR-1 binding sites have previously not been
studied on a whole genome basis. In order to identify novel
target genes or DNA binding sites in the context of the
genome around transcriptional start sites (TSSs), we per-
formed ChIP-chip analysis as a comprehensive and unbiased
approach. Since we hypothesized that EGR-1 would exert its
direct effects on transcriptional regulation by binding pro-
moter regions, human promoter arrays covering approxi-
mately 7.5 kb upstream through 2.45 kb downstream of 5'
TSSs of approximately 25,500 genes were used. For hybridi-
zation, we prepared immunoprecipitated chromatin samples
from THP-1 cells treated with PMA for 1 hour. Members of the
immediate early genes family, including EGR-1, are believed
to constitute the first step in transcriptional regulation and
operate in a hierarchical manner by induction of expression
of downstream factors. Therefore, we predicted that a small
number of binding sites of EGR-1 would be detected in the
array. Surprisingly, however, many were observed. For iden-
tification of high confidence EGR-1 binding sites on the
human promoter arrays, we chose clusters where overlapping
sites in biological replicates had over five consecutive array
probes with a P-value < 1e-6 (see Materials and methods).
Using these criteria, we identified 3,301 clusters, and noticed
that these clusters overlapped the promoters of known EGR-
1 target genes, such as those encoding TNF, NAB2, ID3 and
Co-localization of EGR-1 binding sites with CpG islands Figure 3
Co-localization of EGR-1 binding sites with CpG islands. (a) RefSeq genes, 
and ChIP-chip data of EGR-1 and CpG island location are shown (positions 
50,306,500 to 50,359,500 of human chromosome 3). Signal-enriched 
regions on CpG islands are highlighted in blue boxes. (b) The most 
overrepresented sequence identified by MEME analysis (E-value = 7.5e-
087).
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Effect of siRNA against EGR-1 in THP-1 differentiation Figure 2
Effect of siRNA against EGR-1 in THP-1 differentiation. Photographs show 
typical morphological changes by Giemsa stain in EGR-1 or control siRNA 
transfected THP-1 cells at 48 hours after PMA stimulation. Scale bar = 50 
m.
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SOD1 [17-20], as well as myeloid related genes (Additional
data file 2). Based on previous reports [21] that EGR-1 recog-
nizes a GC rich consensus sequence (5'-WTGCGTGGGCGK-
3'), we predicted that EGR-1 binding sites would localize to
CpG islands to a high extent. Thus, to assess whether EGR-1
and CpG islands co-localized, we compared putative EGR-1
binding loci with the locations of CpG islands obtained from
the UCSC Genome Browser database (Figure 3a). The puta-
tive EGR-1 loci were localized to CpG islands in 77.8% of the
cases.
To search for significantly overrepresented DNA sequences in
the putative EGR-1 binding loci, we used the multiple Em for
motif elicitation (MEME) method. Due to input data size lim-
itations of the web-based MEME application (version 4.1.0)
[22], we randomly selected and analyzed 271 loci (87,782
bases) out of 3,301. The most highly overrepresented
sequence provided by the MEME analysis (E-value = 7.5e-
087) was similar to the previously reported EGR-1 motif (Fig-
ure 3b). In order to validate the criteria used above, we pre-
pared new independent ChIP samples and performed ChIP-
real-time PCR analysis against 50 regions in selected clusters
and 8 negative regions without enrichment in CpG islands.
We observed that all of the 50 regions showed higher enrich-
ment (3.4- to 49.5-fold) than that in negative regions (0.01- to
0.98-fold) (Figure 4 and Additional data file 3). Thus, we used
these criteria in the further analysis.
Co-localization of EGR-1 with histone acetylation and 
transcription start sites
Comparison of ChIP-chip data of EGR-1 with FANTOM4 data
sets (see Materials and methods) revealed that EGR-1 co-
localized with histone H3 lysine 9 acetylation (H3K9ac) sites
in the chromatin samples that were prepared at 0 hour of
PMA stimulation, prior to EGR-1 induction. As a typical case,
direct comparison of EGR-1 and H3K9ac ChIP-chip data
across a 1 Mb region of human chromosome 1 is shown in Fig-
ure 5a. The right side of the screenshot from the genome
browser (human chromosome 1: 151,760,000 to 152,250,000
from build NCBIv36 [hg18]) shows that substantial enrich-
ments for EGR-1 and H3K9ac are predominantly confined to
sharp peaks and that many of these lie at the TSSs of anno-
tated genes, while there is a low number of peaks to the left
(chromosome 1: 151,250,000 to 151,760,000), even though
several Refseq genes were annotated within this region. Since
it is known that H3K9ac modification is tightly associated
with the TSSs of genes, this observation indicated that EGR-1
binding would correlate with chromatin structure and/or
gene expression. As more detailed examples, the nearest sig-
nificant signals of EGR-1 and acetylation of H3K9 around the
TSSs of AGL and ZNF644 are shown (Figure 5b). Two major
peaks surrounding a TSS were detected for H3K9ac, and
EGR-1 enrichment was observed around H3K9ac peaks,
e s p e c i a l l y  i n  t h e  v i c i n i t y  o f  T S S s .  I n t e r e s t i n g l y ,  w e  a l s o
noticed that CAGE (cap analysis gene expression) tags co-
localized with EGR-1 enrichments (Figure 5b). CAGE is a
unique and original TSS identification method that samples
20- or 21-nucleotide sequence tags derived from the proxim-
Validation of EGR-1 enrichment by ChIP-real-time PCR analysis Figure 4
Validation of EGR-1 enrichment by ChIP-real-time PCR analysis. PCR primers were designed to 50 regions in selected clusters and 8 negative regions 
without enrichment in CpG islands. Data are relative fold enrichments, calculated by determining the apparent immunoprecipitation efficiency and 
normalized to the level observed at a control region (mean ± standard deviation, n = 2).
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ity of the cap site of mRNA [23]. Based on the potential EGR-
1 binding regions derived from the above criteria, we exam-
ined the association of the 3,301 EGR-1 clusters with H3K9ac
enriched loci and found that more than 75% of EGR-1 binding
regions were located within 500 bp of H3K9ac enriched loci
(Additional data file 4). Moreover, we observed that 69% of
EGR-1 binding regions were located within 2 kb of CAGE tag
clusters. Together, 87% of EGR-1 binding regions were asso-
ciated with either H3K9ac or CAGE tag clusters. To verify the
status of H3K9ac after PMA stimulation, ChIP-real-time PCR
was carried out by using two EGR-1/H3K9ac enriched
regions (AGL and ZNF644) and three EGR-1 enriched regions
without H3K9ac enrichments (CLSPN, IIP45 and SPOCD1).
As shown in Figure 6, high levels of H3K9ac around EGR-1
enrichments were observed, including two out of the three
H3K9ac negative regions before PMA stimulation, thus dem-
Identification of EGR-1 and H3K9ac enriched sites and CAGE tags in the human genome Figure 5
Identification of EGR-1 and H3K9ac enriched sites and CAGE tags in the human genome. (a) Examples of ChIP-chip data obtained with human promoter 
arrays (position 151,250,000 to 152,250,000 of human chromosome 1). Arrowheads indicate TSSs and direction. (b) EGR-1 co-localizes with H3K9ac and 
CAGE tags at the AGL and ZNF644 loci.
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onstrating new enrichment of H3K9ac. In summary, EGR-1
binding was shown to be highly correlated with acetylation of
H3K9 and TSSs of expressed genes, which suggests that gene
activation is important for EGR-1 target site selection.
Gene Ontology enrichment analysis of EGR-1 target 
genes
In order to further elucidate the functions of EGR-1 target
genes, we examined gene ontologies using the web-based
analysis tool GOstat [24,25]. For 3,301 EGR-1 clusters fully or
partly overlapping RefSeq TSSs within ± 1 kbp, Entrez gene
names were collected. We obtained 2,705 genes in this way,
including several cases where the same cluster overlapped the
TSS region of more than one gene. In the GOstat analysis, the
2,705 genes were compared to 17,142 genes as background
that were identified by the same clustering method with a P-
value of 1. Interestingly, the statistically significantly overrep-
resented Gene Ontology (GO) biological process terms were
highly enriched for nucleic acid-related words such as gene
expression and RNA processing (Table 1). Moreover, with
regard to GO molecular function terms, the EGR-1 target
genes list included binding of nucleic acids and proteins
ChIP-real time PCR validation around EGR-1 enriched regions using THP-1 cell samples 1 hour after PMA treatment Figure 6
ChIP-real time PCR validation around EGR-1 enriched regions using THP-1 cell samples 1 hour after PMA treatment. Relative fold enrichment for H3K9ac 
(red) and EGR-1 (blue) are shown. Two independent experiments were performed, one represented by thin lines and one by thick lines. Gene start and 
direction of transcription are indicated by arrows.
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(Table 2). Information transmission such as transcriptional
and translational cascades begin with binding of molecules,
followed by signal amplification through a combination of
molecular interactions, so we conclude that the results of the
GOstat analysis support the notion that EGR-1 acts as an ini-
tiator of information transmission in cell events.
The influence of EGR-1 occupancy on gene expression 
dynamics
To address whether EGR-1 binding at 1 hour after stimulation
influenced expression of the target genes, mRNA microarray
data in the FANTOM4 data sets, where the levels of various
mRNAs were monitored over a time-course following PMA
stimulation, were interrogated. In order to focus on genes
with early dynamic expression changes, we identified genes
that were up- or down-regulated at least five-fold at any time
point within the first 6 hours after PMA stimulation, com-
pared to the 0 hour initial time point. Out of 7,067 detectable
genes during the whole time course, 209 were either up-reg-
ulated (145) or down-regulated (64) within 6 hours. Since 12
out of the 209 genes were not annotated in the human pro-
moter array, 197 genes were then compared with the 2,705
EGR-1 target genes. Twenty-four up-regulated genes and
eight down-regulated genes were found in the list of EGR-1
target genes and, as expected, immediately up-regulated
genes were associated with EGR-1 binding in their promoter
regions (Table 3). Five out of 21 (24%) and 7 out of 28 (25%)
promoters of identified genes in the groups of up-regulated
transcripts at 1 hour and at 2 hours, respectively, were
Table 1
Enrichment of Gene Ontology biological process terms in ChIP hits with EGR-1
GO term IDs Enriched GO terms P-value
GO:0043170 Macromolecule metabolic process 8.73E-031
GO:0044238 Primary metabolic process 7.20E-029
GO:0044237 Cellular metabolic process 8.44E-028
GO:0043283 Biopolymer metabolic process 4.34E-026
GO:0006139 Nucleobase, nucleoside, nucleotide and nucleic acid metabolic process 6.82E-026
GO:0006259 DNA metabolic process 7.99E-017
GO:0010467 Gene expression 2.98E-016
GO:0015031 Protein transport 3.70E-014
GO:0016070 RNA metabolic process 1.04E-013
GO:0016071 mRNA metabolic process 1.16E-013
GO:0045184 Establishment of protein localization 2.55E-012
GO:0033036 Macromolecule localization 2.80E-012
GO:0005654 Nucleoplasm 3.77E-012
GO:0006396 RNA processing 3.77E-012
GO:0006281 DNA repair 7.32E-012
GO:0006886 Intracellular protein transport 7.66E-012
GO:0008104 Protein localization 4.26E-011
GO:0006260 DNA replication 4.73E-011
GO:0016043 Cellular component organization and biogenesis 1.30E-010
GO:0006974 Response to DNA damage stimulus 1.40E-010
GO:0006397 mRNA processing 2.05E-009
GO:0046907 Intracellular transport 3.40E-009
GO:0008380 RNA splicing 7.02E-009
GO:0007049 Cell cycle 2.81E-007
GO:0022613 Ribonucleoprotein complex biogenesis and assembly 9.37E-007
Table 2
Enrichment of Gene Ontology molecular function terms in ChIP 
hits with EGR-1
GO terms IDs Enriched GO terms P-value
GO:0003676 Nucleic acid binding 3.08E-019
GO:0003723 RNA binding 6.44E-018
GO:0005515 Protein binding 5.65E-009
GO:0000166 Nucleotide binding 3.84E-007
GO:0003677 DNA binding 5.69E-007
GO:0051082 Unfolded protein binding 1.72E-006http://genomebiology.com/2009/10/4/R41 Genome Biology 2009,     Volume 10, Issue 4, Article R41       Kubosaki et al. R41.8
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observed to belong to EGR-1 target genes. In contrast, in the
group of up-regulated transcripts after 4 hours and the group
of down-regulated genes, we did not find similar enrichments
of EGR-1 binding sites in immediately up-regulated genes (0-
14%). The EGR-1 association with early up-regulated genes
was not statistically significant (Fisher's exact test); however,
the small P-value (P = 0.06) suggests that this may be due to
the small sample size. Based on the western blot analysis (Fig-
ure 1b), we hypothesized that EGR-1 plays a role as an activa-
tor, and that the target gene expressions would be affected
until 24 hours after EGR-1 induction, and return to basal lev-
els thereafter. To verify this speculation, of the 2,705 EGR-1
target genes we identified 75 genes whose expression levels
changed dynamically by at least five-fold for at least one time
point over a time course between 0 and 96 hours after stimu-
lation (Figure 7). Unexpectedly, the 75 genes contained not
only transient up-regulated genes but also transient down-
regulated genes and enhanced/suppressed genes at 96 hours
after stimulation. These data suggested that EGR-1 binding
affects multiple steps in the modulation of gene expression.
We speculated, therefore, that multiple responses in gene
expression by EGR-1 binding result from several types of
interplay between EGR-1 and other proteins.
To test the above speculation, the in vivo relationship
between EGR-1 and SP1 in THP-1 differentiation was ana-
lyzed, since transcriptional regulation mediated through the
interplay between EGR-1 and SP1 has been reported previ-
ously [26]. First, the protein level of SP1 was assessed by
western blot analysis during PMA stimulation. Unlike EGR-1,
we observed that SP1 expression gradually increased (Addi-
tional data file 5) throughout the time course. Second, to find
SP1 sites coinciding with EGR-1 enriched loci, EGR-1 ChIP-
chip data were compared to SP1 ChIP-chip results at PMA
pre-stimulation, which had been produced previously as one
of the FANTOM4 data sets (see Materials and methods). In
this analysis, we found that 48-53% of EGR-1 sites were iden-
tical to SP1 sites with high confidence (Additional data file 6).
In 75 dynamically changed EGR-1 target genes, we found that
34 loci (45.3%) were identical to SP1 sites. Finally, to examine
the binding dynamics of EGR-1 and SP1 at the co-localized
sites, six genes (ARL4A, ABHD2, IDS, NASP, TBC1D2, GCLC)
out of the 34 identified loci were manually selected and the
kinetics of EGR-1 and SP1 binding in vivo were assessed. By
using ChIP-real-time PCR analysis, PMA treatment-induced
EGR-1 binding at all examined loci was observed (Figure 8).
ChIP experiments with anti-SP1 antibodies showed that SP1
binding occupancy in TBC1D2 and GCLC increased following
PMA treatment, and indicated that SP1 occupancy in both loci
was positively correlated with EGR-1 occupancy and the
amounts of SP1 protein in the nucleus. On the other hand, SP1
binding occupancies in promoter regions of four genes
(ARL4A, ABHD2, IDS, NASP) showed inverse relationships
to EGR-1 occupancies.
Expression profile of dynamically changed EGR-1 target genes over a  period of 96 hours after PMA stimulation Figure 7
Expression profile of dynamically changed EGR-1 target genes over a 
period of 96 hours after PMA stimulation. Seventy-five genes, which 
changed expression relative to pre-stimulation by at least fivefold for at 
least one of the time points, are shown. Red, green and black denote 
increased, decreased and no change in gene expression.
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Discussion
Several transcription factors, especially EGR-1, have been
implicated in differentiation of human monoblastoma cells
along the monocytic commitment following treatment with
PMA. EGR-1 has been thought to work as a modifier of
monopoiesis, but it has not been clear where immediately
induced EGR-1 is distributed throughout the genome. The
results of the study presented here indicate that EGR-1
mainly recognizes GC-rich consensus sequences of active
genes in CpG islands. CpG island promoters are most often
associated with ubiquitously expressed genes, so-called
housekeeping genes, but are also associated with many excep-
tions to this, including embryonic development and brain-
specific genes [27,28]. Previous reports have shown that not
only chromatin structure, but also DNA methylation in CpG
islands, can control gene expression [29]. Ogishima et al. [30]
reported that DNA hypomethylation within promoter CpG
islands of the gene encoding heparanase facilitated EGR-1
binding to its consensus motif. Since DNA methylation in
CpG islands is generally associated with gene silencing, and
with regard to our results, it is reasonable to suggest that
EGR-1 cannot bind methylated GC-rich regions of promoters.
Here, we have performed the first study of in vivo occupancy
changes of EGR-1 and its counterpart following stimulation.
Our data show that both EGR-1 and SP1 binding occupancies
change dramatically. EGR-1 binding may influence the occu-
pancy of previous binding proteins, resulting in the recon-
struction of the transcription factor complex and the
i n d u c t i o n  o f  g e n e  e x p r e s s i o n  c h a n g e s ,  a l t h o u g h  f u r t h e r
experiments need to be performed in order to assess this. Of
particular interest in this study was the reduction in occu-
pancy of SP1 binding. A previous in vitro study reported that
EGR-1 binding competed with SP1 binding because of similar
consensus sequences [31]. Similar competition between the
protein pair Hox and Smad have been reported [32]. We then
speculate that EGR-1 could antagonize other GC-rich region
binding proteins in addition to SP1. Since the most overrepre-
sented sequence of EGR-1 binding regions is similar to that of
not only SP1 but also SP3 (Figure 3b), SP3 may be a candidate
competitor of EGR-1. SP3 has been reported to act as a dual-
functional regulator whose activity is dependent on the con-
text of DNA-binding sites in promoters. SP3 functions as a
repressor when it is bound to a promoter through multiple
DNA-binding sites, and as an activator when targeted to a
promoter through a single DNA binding site [33]. Moreover,
Leibermann and Hoffman reported that ectopic expression of
EGR-1 abrogated the block in terminal differentiation
impaired by Myc and E2F1, which can bind GC-rich consen-
sus sequences [34,35]. We therefore guess that EGR-1 may
influence the occupancy of Myc and E2F1 on their target gene
promoters, as well as the down-regulation of Myc and E2F1
expression directly and/or indirectly.
The NGFI-A/EGR-1 binding proteins NAB1 and NAB2 have
been reported as negative transcriptional cofactors capable of
binding directly to EGR-1 and repressing EGR-1-mediated
transcription [36,37]. In this study, enrichment of EGR-1
binding at 1 hour after PMA stimulation were observed in
both NAB1 and NAB2 promoter regions (Figure 4). Moreover,
the microarray data in FANTOM4 data sets showed that both
NAB1 and NAB2 mRNA were induced until 2 hours after PMA
treatment and decreased thereafter (Additional data file 7).
These data strongly indicate that NAB1 and NAB2 are directly
up-regulated by EGR-1 in THP-1 differentiation. Although
NAB protein levels and the genome-wide locations of where
EGR-1/NAB complexes bind have not been determined, our
observation that NAB  mRNAs are transiently expressed
implies that direct repression by NAB proteins of EGR-1
transactivation during PMA stimulation may occur tran-
siently. On the other hand, a current report showing that
NAB2 interacts with the nucleosome remodeling and
deacetylase complex suggests that a EGR-1/NAB complex
could modify chromatin status [38]. Our investigation and
further studies of epigenetic changes in THP-1 differentiation
may contribute to elucidate the mechanisms of EGR-1/NAB
transcriptional regulation.
Recently, a study of EGR-1 target genes in UV irradiated
human prostate M12 cells was published [39]. To identify
overlapping genes within both gene lists, we compared our
2,705 selected genes in PMA-stimulated THP-1 cells with 288
genes in UV irradiated M12 cells, and found 33 genes present
in both lists. Interestingly, 19 of the 33 overlapping genes
Table 3
Number of genes showing changes in early dynamic expression after PMA treatment with promoter regions that are bound by EGR-1
Number of promoters bound at time points after PMA treatment
1 hour 2 hours 4 hours 6 hours
Up-regulated 5 (23.8%) 7 (25.0%) 9 (14.3%) 3 (12.5%)
Down-regulated 0 (0%) 0 (0%) 4 (13.8%) 4 (12.9%)
After PMA treatment, 136 genes were up-regulated and 61 down-regulated. Of these, 24 and 8, respectively, were found to be EGR-1 target genes. 
Percentage values indicate the number of target genes with bound promoters whose expression was up- or down-regulated at the indicated time 
point out of all EGR-1 target genes up- or down-regulated, respectively, over the entire time course (0-6 hours).http://genomebiology.com/2009/10/4/R41 Genome Biology 2009,     Volume 10, Issue 4, Article R41       Kubosaki et al. R41.10
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Relative occupancy changes of EGR-1 and SP1 in response to PMA stimulation Figure 8
Relative occupancy changes of EGR-1 and SP1 in response to PMA stimulation. ChIP samples against EGR-1 or SP1 were prepared at the appropriate time, 
followed by real-time PCR of ChIP enriched DNA. Solid and broken lines show the relative fold enrichment of independent experiments.
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were closely related to nucleic acid binding, including tran-
scription factor activity (BLZF1, EGR2, ELF2, HLX1, ISL2,
ZNF207), transcription regulator activity (CITED4), DNA
binding (ORC6L, TAF6, ZNF345, ZNF565), nucleic acid bind-
ing (PINX1), nucleotide binding (GMPS,  NME1), histone
(H3F3A), RNA splicing factor activity (KHSRP), RNA splic-
ing (PPIH,  IVNS1ABP) and RNA binding (ADAR). This
enrichment strongly supports our conclusion that EGR-1 acts
as an initiator of information transmission in cell events.
Moreover, the observation that many genes do not overlap
indicates that EGR-1 binding to DNA is dependent on cell
type and/or stimulus. This observation also supports our
notion that gene activation is important for EGR-1 binding.
Two independent lines of Egr-1 knockout mice have been
reported [40,41]. Lee and colleagues [40] produced a defi-
cient mouse line by homologous recombination using target-
ing vectors that localized at the beginning of the region
encoding the first zinc finger in exon 2, whereas the mouse
generated by Topiliko et al. [41] had the lacZ and neomycin
genes inserted 50 bp upstream of the Egr-1 initiation codon in
exon 1. Although both knockout mice were born normally,
they exhibited individual abnormalities in growth, reproduc-
tion and long-term potentiation of neurons [42,43]. With
regard to macrophage differentiation, a study that used the
mice generated by Topiliko et al. argued that Egr-1 was a
major positive modulator of macrophage differentiation [44],
while Carter and Tourtellotte, who used the mice generated
by Lee, showed that Egr-1 was neither essential for nor spe-
cific to monocyte/macrophage differentiation [45]. There are
several possible explanations for these differences in pheno-
type between knockout mice lines. First, the location of the
deletion in the gene may affect the expression of other genes,
which is the case in prion gene (Prnp) knockout mice [46]. A
couple of knockout mouse lines with targeted disruption of
the coding gene Prnp were independently generated and two
strikingly different phenotypes were reported. A group of
knockout lines without prion protein expression produced
ectopic Doppel, which is encoded by sequence 16 kb down-
stream of Prnp and has approximately 25% identity with the
carboxy-terminal two-thirds of Prnp, and resulted in a cere-
bellar syndrome phenotype. Second, genes may be expressed
from alternative start sites and avoid the impact of the target-
ing cassette insertion. In fact, the CAGE analysis from the
FANTOM4 data has revealed that EGR-1 mRNAs are tran-
scribed from a couple of alternative start sites (Additional
data file 8). This result raises the possibility that alternative
isoforms, which play a complementary or competitive role,
may be produced from the EGR-1 locus.
Conclusions
Here, we present the first genome-wide analysis of EGR-1
binding sites implicated in cell differentiation in human
monoblastoma THP-1 cells. By combining genome context
information, epigenetic profiling data and TSS identification,
we conclude that EGR-1 mainly recognizes GC-rich consensus
sequences of active genes in CpG islands. Using GOstat anal-
ysis, GO terms for EGR-1 target genes that were enriched
included binding of nucleic acids and proteins. In addition,
comparison with gene expression profiling data showed that
immediately up-regulated genes are associated with EGR-1
binding in their promoter regions. These results confirm that
EGR-1 acts as an initiator of information transmission in cell
events. Moreover, we have demonstrated the first observation
of in vivo occupancy changes of EGR-1 and SP1 following
PMA stimulation. SP1 binding occupancies were dramatically
changed near EGR-1 binding sites, suggesting that EGR-1
binding influences the occupancy of previous binding pro-
teins. These observations may help explain why EGR-1 bind-
ing results in multiple responses to downstream genes.
Materials and methods
Cell culture and siRNA transfection
THP-1 cells were grown in RPMI1640 (Invitrogen, Carlsbad,
CA, USA), 10% fetal bovine serum, 1% penicillin/streptomy-
cin (Invitrogen), 10 mM HEPES (Invitrogen), 1 mM sodium
pyruvate (Invitrogen) and 50 M 2-mercaptoethanol (Invit-
rogen). THP-1 cells were incubated at 37°C in a humidified
5% CO2 incubator and differentiated with 30 ng/ml PMA
(Sigma, St. Louis, MO, USA) up to 96 hours. Alexa Fluor 555
conjugated Stealth siRNA against EGR-1 (5'-UCUCCCAG-
GACAAUUGAAAUUUGCU-3') and a negative control siRNA
were purchased from Invitrogen. For siRNA transfection,
THP-1 cells were seeded in 6 cm dishes at a density of 1 × 106
cells/dish. Transfection was performed with 1.6 mg/ml (final
concentration) of Lipofectamine 2000 (Invitrogen) and 20
nM (final concentration) of stealth siRNA by reverse transfec-
tion protocol in accordance with the manufacturer's instruc-
tions. Following siRNA treatment (48 hours), cells were
incubated with PMA for differentiation. Cells were stained
with Giemsa solution (Wako, Osaka, Japan) after fixing by
methanol.
Western blot analysis
Nuclear extracts taken at appropriate PMA stimulation times
were prepared using NE-PER nuclear and cytoplasmic
extraction reagents (Pierce, Rockford, IL, USA) according to
the manufacturer's instructions. Total protein (20 g) from
each preparation were separated by SDS-PAGE in a 4-12%
gradient NuPAGE polyacrylamide gel (Invitrogen) and trans-
ferred onto a PVDF membrane. Blots were incubated with
rabbit anti-EGR1 polyclonal (#4152, Cell Signaling, Danvers,
MA, USA) or rabbit anti-SP1 polyclonal (#07-645, Millipore,
Billerica, MA, USA) antibodies and HRP-conjugated second
antibodies and then were developed by the ECL Advance
western blotting detection kit (GE Healthcare, Buckingam-
shire, UK). The chemiluminescence was recorded with a LAS-
3000 luminescent image analyzer (Fujifilm, Tokyo, Japan).http://genomebiology.com/2009/10/4/R41 Genome Biology 2009,     Volume 10, Issue 4, Article R41       Kubosaki et al. R41.12
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Chromatin immunoprecipitation assay
ChIP assays were performed as described previously [47] with
minor modifications. The cells were cross-linked with 1% for-
maldehyde (Wako) for 10 minutes followed by addition of gly-
cine (Wako) in phosphate-buffered saline at a final
concentration of 125 mM. The cross-linked cells were col-
lected by centrifugation and washed twice in cold 1× phos-
phate-buffered saline. The cells were sonicated for 5 minutes
with a Branson 450 Sonicator to reduce the total DNA size
from 150 to 600 bp (Additional data file 1c). The sheared
chromatins were immunoprecipitated with anti-EGR1, anti-
SP1, rabbit anti-acetyl-histone H3 Lys9 (#07-352, Millipore)
antibodies or normal rabbit IgG (#12-370, Millipore) over-
night at 4°C on a rotator. Immunoprecipitated samples were
incubated with magnetic beads/Protein G (Invitrogen) for 1
hour at 4°C. Magnetic bead-antibody-chromatin complexes
were washed once with low salt, high salt and LiCl buffers and
twice with TE buffer. The chromatin complexes were eluted
and incubated for 3.5 hours at 65°C to reverse the crosslink.
To purify the DNA, RNA and proteins were digested with 20
g/ml RNase and 100 g/ml proteinase K, respectively. The
DNA samples were recovered by phenol:chloroform:isoamyl
alcohol extraction or QIAquick PCR purification kit (Qiagen,
Valencia, CA, USA).
LM-PCR, array hybridization and analysis of Affymetrix 
tiling array data
Immunoprecipitated DNA was blunted using 0.25 U/l T4
DNA polymerase (Nippon Gene, Tokyo, Japan). Linker oligo-
nucleotides (5'-accgcgcgtaatacgactcactataggg-3' and phos-
phate-5'-ccctatagtgagtcgtattaca-3') were annealed while the
temperature was decreased gradually from 99°C to 15°C over
90 minutes. The blunted immunoprecipitated DNA sample
was ligated with the annealed oligonucleotides by using 5 U/
l T4 DNA ligase (Nippon Gene). The cassette DNA frag-
ments (60 g/reaction) were amplified by using Blend Taq
Plus (Toyobo, Osaka, Japan) with the linker-specific oligonu-
cleotide 5'-accgcgcgtaatacgactcactataggg-3'. PCR amplifica-
tion was done under the following conditions: denaturation at
95°C for 1 minute; 25 cycles of 95°C for 30 s, 55°C for 30 s,
72°C for 2 minutes; and a final extension at 72°C for 7 min-
utes. Amplified DNA was purified, fragmented with DNase I
(Epicentre, Madison, WI, USA), and end-labeled with biotin-
ddATP by using terminal deoxytransferase (Roche, Basel,
Switzerland). Arrays were hybridized for 18 h at 45°C,
washed, and scanned using the Affymetrix GeneChip System.
The enriched and input samples were hybridized in triplicate.
Raw array data were quantile normalized within three
enriched and input technical replicates and scaled to a
median feature intensity of 500. The genome coordinates of
the 25-mer probes, originally based on version hg16 of the
human genome, were converted to hg18. The positions of the
p r o b e s  o n  h g 1 8  w e r e  d e t e r m i n e d  b y  a l i g n i n g  t h e  p r o b e
sequences to the human genome (hg18) using Vmatch [48].
For identification of high confidence EGR-1 binding sites on
the human promoter arrays, we performed two independent
experiments and chose clusters, where overlapping sites in
biological replicates had over five consecutive array probes
with a P-value < 1e-6.
Real-time PCR for ChIP samples
For ChIP samples, real-time PCR was carried out using SYBR
Premix ExTaq (Takara Bio Inc., Otsu, Japan) on the ABI
PRISM 7500 Fast Real-Time PCR System (Applied Biosys-
tems, Foster City, CA, USA) by denaturation at 95°C for 10 s,
followed by running for 40 cycles at 95°C for 5 s and 62.5°C
for 20 s. Occupancy values at each time point were calculated
by determining the apparent immunoprecipitation efficiency
(ratios of the amount of immunoprecipitated DNA over that
of the input sample) and normalized to the level observed at a
control region (Additional data file 9). Relative fold enrich-
ment was calculated as the ratio fold enrichment of each sam-
ple to the 0 hour occupancy value. The primer sets used for
real-time PCR analysis are shown in Additional data file 9.
Data
The raw EGR-1 ChIP-chip data have been submitted to the
Center for Information Biology Gene Expression database
(CIBEX) with accession number [CIBEX:CBX71]. Illumina
microarray gene expression data, Affymetrix whole tiling
array data for H3K9ac enriched regions and promoter array
data for SP1 binding regions are accessible through CIBEX
accession numbers [CIBEX:CBX46], [CIBEX:CBX48], and
[CIBEX:CBX43], respectively. All data, including that from
deepCAGE, are also available via the Genome Network Plat-
form [15]. The protein sequences of EGR-1 [Swiss-
Prot:P18146], EGR-2 [Swiss-Prot:P11161], EGR-3 [Swiss-
Prot:Q06889], EGR-4 [Swiss-Prot:Q05215] and WT-1
[Swiss-Prot:P19544] were used for motif analysis. In this
paper, H3K9ac enriched loci are defined as a stretch of at least
five consecutive array probes with a score (-log10 (P-value))
of over 30. High confidence SP1 enriched sites are defined as
those with over five consecutive array probes in both biologi-
cal replicates with a score  50.
Abbreviations
CAGE: cap analysis gene expression; ChIP-chip: chromatin
immunoprecipitation with genome tiling array; EGR: Early
growth response gene; GO: Gene Ontology; H3K9ac: histone
H3 lysine 9 acetylation; MEME: multiple Em for motif elici-
tation; PMA: phorbol 12-myristate 13-acetate; siRNA: small
interfering RNA; TSS: transcriptional start site.
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Additional data files
The following additional data are available with the online
version of this paper: a PowerPoint file containing three fig-
ures showing EGR-1  mRNA levels after siRNA mediated
knockdown, differentiated THP-1 cells after siRNA mediated
knockdown, and sonicated DNA (Additional data file 1); an
Excel table listing myeloid related genes within predicted
EGR-1 targets (Additional data file 2); a PowerPoint figure
depicting the validation of EGR-1 enrichment by ChIP-real-
time PCR analysis using EGR-1 antibody and normal IgG
(Additional data file 3); PowerPoint Venn diagrams of the
overlaps between EGR-1 binding sites, H3K9ac domains and
CAGE tag clusters (Additional data file 4); a PowerPoint fig-
ure of SP1 protein levels in PMA-treated THP-1 cells (Addi-
tional data file 5); PowerPoint Venn diagrams of the overlaps
between EGR-1 binding sites and SP1 binding sites (Addi-
tional data file 6); a PowerPoint figure showing NAB1 and
NAB2 expression during THP-1 differentiation (Additional
data file 7); a PowerPoint figure depicting TSSs in the EGR-1
gene locus (Additional data file 8); an Excel table listing real-
time PCR primers for ChIP samples (Additional data file 9).
Additional data file 1 EGR-1 mRNA levels after siRNA mediated knockdown, effect of  siRNA on EGR-1 in THP-1 differentiation, and sonicated DNA (a) siRNA mediated knockdown of EGR-1 mRNA. EGR-1 mRNA  were quantified using quantitative RT-PCR. EGR-1 mRNA levels  were normalized to GAPDH mRNA and are presented relative to  RNA levels in mock cells. RNA levels are representative of four  independent experiments. (b) Effect of siRNA on EGR-1 in THP-1  differentiation. Phase contrast and fluorescence images were taken  at the same time. Photographs show transfect efficiency indicated  by Alexa Fluor 555 (upper) and typical morphological changes in  EGR-1 or control siRNA transfected THP-1 cells at 48 hours after  PMA stimulation (lower). The white arrows indicate differentiating  THP-1 cells. (c) A sample of sonicated DNA. The sonication condi- tions were optimized to achieve enrichment of fragments between  150 and 600 bp in length. Click here for file Additional data file 2 Myeloid related genes within predicted EGR-1 targets Myeloid related genes within predicted EGR-1 targets. Click here for file Additional data file 3 Validation of EGR-1 enrichment by ChIP-real-time PCR analysis  using EGR-1 antibody and normal IgG PCR primers were designed for nine regions in selected clusters  and six negative regions without enrichment in CpG islands. Data  are relative fold enrichments, calculated by determining the appar- ent immunoprecipitation efficiency and normalized to the level  observed at a control region (mean ± standard deviation, n = 2). Click here for file Additional data file 4 Schematic Venn diagram representing the overlaps between EGR- 1 binding sites, H3K9ac domains of each biological replicate and  CAGE tag clusters Schematic Venn diagram representing the overlaps between EGR- 1 binding sites, H3K9ac domains of each biological replicate and  CAGE tag clusters. Click here for file Additional data file 5 SP1 protein levels in PMA-treated THP-1 cells SP1 protein levels over a time course following PMA stimulation  were observed by western blot analysis using a specific polyclonal  antibody. Click here for file Additional data file 6 Venn diagram showing the overlaps between EGR-1 binding sites  and SP1 binding sites of each biological replicate Venn diagram showing the overlaps between EGR-1 binding sites  and SP1 binding sites of each biological replicate. Click here for file Additional data file 7 NAB1 and NAB2 expression during THP-1 differentiation Quantile normalized NAB1 and NAB2 transcript levels were pro- duced by Illumina Human Sentrix-6 bead chips v.2. Click here for file Additional data file 8 Transcriptional start sites in the EGR-1 gene locus deepCAGE tag clusters indicate transcriptional start sites in THP-1  differentiation. Click here for file Additional data file 9 Real-time PCR primers for ChIP samples Real-time PCR primers for ChIP samples. Click here for file
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